Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette Conrads-Frank

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Applied Health Economics and Health Policy|April 25, 2019
Budget Impact Analysis of Cancer Screening: A Methodological ReviewBeate Jahn, Jovan Todorovic, Marvin Bundo, et al.
Atherosclerosis|July 23, 2022
Familial hypercholesterolemia: A systematic review of modeling studies on screening interventionsBeate Jahn, Júlia Santamaria, Hans Dieplinger, et al.
Annals of Hematology|September 3, 2021
The anemia-independent impact of myelodysplastic syndromes on health-related quality of lifeHanneke J C M Wouters, Annette Conrads-Frank, Karin A Koinig, et al.
Journal of Comparative Effectiveness Research|September 13, 2019
Guidance for a causal comparative effectiveness analysis emulating a target trial based on big real world evidence: when to start statin treatmentFelicitas Kuehne, Beate Jahn, Annette Conrads-Frank, et al.
European Journal of Epidemiology|September 21, 2014
BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countriesTanja Zeller, Maria Hughes, Tarja Tuovinen, et al.
British Journal of Haematology|May 16, 2020
Development of a core outcome set for myelodysplastic syndromes - a Delphi study from the EUMDS Registry GroupUrsula Rochau, Igor Stojkov, Annette Conrads-Frank, et al.
Blood Advances|September 7, 2021
Core set of patient-reported outcomes for myelodysplastic syndromes: an EUMDS Delphi study involving patients and hematologistsIgor Stojkov, Annette Conrads-Frank, Ursula Rochau, et al.
Plos One|July 19, 2024
Cost-effectiveness of applying high-sensitivity troponin I to a score for cardiovascular risk prediction in asymptomatic populationPaul Jülicher, Nataliya Makarova, Francisco Ojeda, et al.
Blood Advances|January 6, 2023
Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry studyIgor Stojkov, Annette Conrads-Frank, Ursula Rochau, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Applied Health Economics and Health Policy|April 25, 2019
Budget Impact Analysis of Cancer Screening: A Methodological ReviewBeate Jahn, Jovan Todorovic, Marvin Bundo, et al.
Atherosclerosis|July 23, 2022
Familial hypercholesterolemia: A systematic review of modeling studies on screening interventionsBeate Jahn, Júlia Santamaria, Hans Dieplinger, et al.
Annals of Hematology|September 3, 2021
The anemia-independent impact of myelodysplastic syndromes on health-related quality of lifeHanneke J C M Wouters, Annette Conrads-Frank, Karin A Koinig, et al.
Journal of Comparative Effectiveness Research|September 13, 2019
Guidance for a causal comparative effectiveness analysis emulating a target trial based on big real world evidence: when to start statin treatmentFelicitas Kuehne, Beate Jahn, Annette Conrads-Frank, et al.
European Journal of Epidemiology|September 21, 2014
BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countriesTanja Zeller, Maria Hughes, Tarja Tuovinen, et al.
British Journal of Haematology|May 16, 2020
Development of a core outcome set for myelodysplastic syndromes - a Delphi study from the EUMDS Registry GroupUrsula Rochau, Igor Stojkov, Annette Conrads-Frank, et al.
Blood Advances|September 7, 2021
Core set of patient-reported outcomes for myelodysplastic syndromes: an EUMDS Delphi study involving patients and hematologistsIgor Stojkov, Annette Conrads-Frank, Ursula Rochau, et al.
Plos One|July 19, 2024
Cost-effectiveness of applying high-sensitivity troponin I to a score for cardiovascular risk prediction in asymptomatic populationPaul Jülicher, Nataliya Makarova, Francisco Ojeda, et al.
Blood Advances|January 6, 2023
Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry studyIgor Stojkov, Annette Conrads-Frank, Ursula Rochau, et al.
Pageof 3